Nutraceuticals Research Group, School of Biomedical Sciences & Pharmacy, University of Newcastle, NSW, Australia.
Semin Thromb Hemost. 2011 Apr;37(3):199-208. doi: 10.1055/s-0031-1273084. Epub 2011 Mar 31.
An increased prothrombotic state is a major risk factor for the development of heart attacks, strokes, and venous thromboembolism. Platelet activation and aggregation play an important role in determining a prothrombotic state. Although pharmaceutical agents such as aspirin, heparin, and warfarin are able to reduce prothrombotic tendency, long-term drug treatment may produce a variety of side effects, including bleeding. Diet is generally recognized to be significantly involved in modifying the individual risk for the development of thrombotic diseases, although its influence during the treatment of these disorders is probably less important. Dietary intervention has proven effective in lowering serum lipid levels, which are otherwise essential elements in the pathogenesis of cardiovascular disease. Likewise, certain dietary components have also been proven effective in decreasing platelet activation through various mechanisms and therefore may contribute to attenuating the future risk of thrombosis. This article provides an up-to-date review of the role of nutrient and nonnutrient supplements on platelet aggregation and risk of thrombosis.
高凝状态是导致心脏病发作、中风和静脉血栓栓塞的主要危险因素。血小板的激活和聚集在决定高凝状态中起着重要作用。虽然阿司匹林、肝素和华法林等药物能够降低高凝倾向,但长期药物治疗可能会产生各种副作用,包括出血。饮食通常被认为可以显著改变个体发生血栓性疾病的风险,尽管其在治疗这些疾病中的影响可能不太重要。饮食干预已被证明可有效降低血清脂质水平,而脂质水平是心血管疾病发病机制中的重要因素。同样,某些膳食成分也已被证明可通过多种机制有效降低血小板的激活,从而有助于降低未来的血栓形成风险。本文就营养素和非营养素补充剂对血小板聚集和血栓形成风险的作用进行了最新综述。